news

DSM and Avril to collaborate on plant-based product

Posted: 10 July 2019 | | No comments yet

DSM and Avril will produce a unique protein based on non-genetically modified canola.

They will aim to produce a unique protein based on non-genetically modified canola which has a high nutritional value.

Royal DSM, a global science-based company which is active in health, nutrition, and sustainable living, and Avril, an international French agro-industrial group, intend to collaborate to meet the growing consumer demand for plant-based proteins.

Together, they will collaborate to produce a unique protein based on non-genetically modified canola which has a high nutritional value and a balanced taste profile. This makes it ideal for a range of applications including meat and dairy alternatives, beverages, baked products, bars and ready-to-mix products.

“More people are opting for flexitarian, vegetarian and vegan diets for personal, health and environmental reasons.

“With our expertise, DSM can support all forms of proteins produced to the highest sustainable standards,” said Trish Malarkey, Chief Innovation Officer at DSM. “With Avril as a partner, we will be  uniquely positioned to serve this growing market and look forward to helping our customers deliver great tasting, healthy, and sustainable food and beverages.” 

“Avril and DSM intend to join forces to contribute through innovation,” says Avril CEO Jean-Philippe Puig.

“With 10 billion inhabitants by 2050, experts predict global demand for both animal and plant-based protein to grow, with exponential growth in plant-based proteins due to dietary shifts,” added Jean-Philippe Puig, CEO at Avril. “Through this collaboration, Avril and DSM intend to join forces to contribute through innovation to meet the growing demand.”

The partners’ ambition is to develop a state-of-the-art industrial production facility fully dedicated to canola proteins at Avril’s Saipol facility in Dieppe. They predict that commercial availability from the first production could be as early as the end of 2021.